Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 79, pseudogene (RN7SL79P)

Target
RN7SL79P
Molecular classification
Other, Pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 7SL, cytoplasmic 79, pseudogene (RN7SL79P) is a non-coding RNA pseudogene, homologous to the functional Signal Recognition Particle RNA (7SL RNA), but it is not itself functional. Pseudogenes are stretches of DNA that are similar to known genes but are nonfunctional due to disabling mutations or lack of necessary regulatory features[4]. This pseudogene does not encode a functional product and does not have known biological function or disease association, nor is it a known therapeutic target. RN7SL79P is one of many pseudogenes derived from the extensively conserved signal recognition particle RNA gene family whose functional member (7SL RNA) is an essential ribonucleoprotein component in the co-translational targeting of proteins to membranes, but the pseudogene versions—including RN7SL79P—lack such function[5][4]. Key points: - RN7SL79P is not a therapeutic target; it is a nonfunctional pseudogene[4]. - No known interacting drugs, biomarkers, safety concerns, or mechanisms of action. - The entry is technically incorrect as a drug target, since it is not a protein, receptor, enzyme, or functional non-coding RNA. - Aliases are limited to its systematic gene symbol, with no common alternative names[2]. This summary enables accurate structured extraction and highlights that this entity should not be treated as a druggable or functional target in biomedical contexts.

Other names
RN7SL79P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 79, pseudogene (RN7SL79P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 79, pseudogene (RN7SL79P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call